Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-28, Stock:JNJ, The news for the past five days is as follows:
2020-01-21: NEWS1: Triad label printing firm grows on technology investment.NEWS2: Johnson & Johnson's Q4 Earnings Outlook.NEWS3: Day Ahead: Top 3 Things to Watch for Jan. 22.NEWS4: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS5: Pharma firms not making enough progress against superbugs - report.
2020-01-22: NEWS1: Dow Jones Medical Giant Johnson & Johnson Slips On Mixed Quarter.NEWS2: US STOCKS-S&P 500, Nasdaq hit record highs on IBM, chip power.NEWS3: US Markets in the Green on Wednesday.NEWS4: Johnson & Johnson's Earnings Surpass Expectations, but Revenue Falls Short.NEWS5: Why one stock-market bull says he’s taking the ‘offense off the field’.NEWS6: US STOCKS-S&P 500, Nasdaq hit record highs on IBM, chip power.NEWS7: J&J Looks to Fend Off Challenges to Key Drugs, Consumer Products.NEWS8: J&J forecasts weak annual profit, misses revenue estimates.NEWS9: Breaking Q4 Earnings News.NEWS10: Johnson & Johnson misses revenue estimates.NEWS11: J&J's (JNJ) Q4 Earnings Surpass Estimates, Sales Fall Short.NEWS12: US STOCKS-S&P 500, Nasdaq hit record on IBM, waning China virus fears.NEWS13: Chicago Econ Numbers & More Q4 Earnings: JNJ, ABT, FITB.NEWS14: Stocks shrug off China virus fears to try for fresh records.NEWS15: Dow Jones Today: IBM, Tesla Lead, Netflix Slips, As Stock Market Looks For A Bounce.NEWS16: IBM, Netflix Earnings Greeted With Enthusiasm, And Texas Instruments Up Later Today.NEWS17: Johnson & Johnson’s Earnings Were Good Enough for Wall Street Analysts. The Stock Is Falling Anyway..NEWS18: Rally Pauses as Coronavirus Spreads to U.S..NEWS19: US STOCKS-S&P 500, Nasdaq aim for record on IBM earnings, fading China virus fears.NEWS20: What to Watch Wednesday: Tesla's Market Cap, Apple's New iPhone and Johnson & Johnson.NEWS21: IBM Stock Is Surging, J&J Slips as China Virus Fears Fade and the Dow Gains.NEWS22: The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings.NEWS23: Dow getting a 22-point boost from IBM's stock rally, J&J's decline after earnings.NEWS24: US STOCKS-S&P 500 aims for record open on IBM support, fading China virus fears.NEWS25: Johnson & Johnson (JNJ) Q4 Earnings Beat Estimates.NEWS26: Johnson & Johnson Reports Mixed Q4 Earnings.NEWS27: Johnson & Johnson Earnings Mixed; JNJ Stock Falls.NEWS28: Johnson & Johnson's stock slips after profit rises above expectations, but sales comes up a bit shy.NEWS29: Johnson & Johnson Tops Q4 Earnings Forecast, But Light Revenue, Remicade Sales Hit Shares.NEWS30: Stocks - J&J, Boeing, Netflix Fall in Premarket After Updates.NEWS31: Stocks - Wall Street to Push Higher; Netflix, IBM Gain.NEWS32: J&J Raises Underlying Guidance After Strong Q4, but Legal Risks Linger.
2020-01-23: NEWS1: Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments.NEWS2: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS3: US Indexes End Mostly Flat Wednesday.NEWS4: This Medical Giant Just Topped An Entry — Should You Buy ABT Stock Now?.NEWS5: JNJ Stock Recently Hit A Fresh High — Is It Time To Buy Shares?.NEWS6: Johnson & Johnson Sold a Hot Biotech Stock.
2020-01-24: NEWS1: Johnson & Johnson Stock at Cusp of Historic Breakout.NEWS2: Top Stock Research Reports for Intel, Boeing & Blackstone.NEWS3: Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU.NEWS4: J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children.
2020-01-27: NEWS1:  J&J CEO testifies: 'I did not read all the documents'.NEWS2: CDC officials say coronavirus is similar to SARS, no new U.S. cases reported.NEWS3: Your 6-point plan to navigating a choppy stock market.NEWS4: J&J CEO questioned over stock sale ahead of story on asbestos in Baby Powder.NEWS5: J&J CEO questioned over stock sale ahead of story on asbestos in Baby Powder.NEWS6: Johnson & Johnson Is 'Confident' In Ability To Treat Coronavirus, But Vaccine Could Take Time.NEWS7: Coronavirus Ends Weekly Winning Streaks.NEWS8: J&J CEO to testify at trial for first time on Baby Powder risks.NEWS9: J&J Confident of Development of Coronavirus Vaccine; Credit Suisse Boosts Price Target.

Answer: Rise